Health Condition 1: F321- Major depressive disorder, singleepisode, moderate Health Condition 2: F419- Anxiety disorder, unspecified Health Condition 3: Z733- Stress, not elsewhere classified
Conditions
Interventions
Intervention1: Individualized Homeopathic Medicines plus yoga therapy: Intervention is planned as
administering indicated
homoeopathic medicines in
centesimal potencies (CH).
Each dose will consist of
Sponsors
Dept of Science and Technology and Biotechnology Govt of West Bengal
Eligibility
Inclusion criteria
Inclusion criteria: a) Cases suffering from depression, stress, and anxiety, diagnosed as per DSM-V criteria. b) Age between 12 and 30 years c) Participants of either sex d) Literate patients ability to read and write in English, Hindi, or Bengali. e) Providing with written informed consent voluntarily
Exclusion criteria
Exclusion criteria: a) Severe or very severe depression (HDRS more than 19) with suicide attempt b) Patients with other psychiatric diseases, e.g., schizophrenia or other psychotic disorders, bipolar affective disorder, schizoaffective disorders, alcohol or other substance abuse, eating disorders, psychosis, mania, hypomania or any other anxiety disorder except panic disorder, personality disorders, history of seizures c) A clinically significant acute or chronic disease that would hinder regular participation in the study d) Treatment with antipsychotics, antidepressants, sedatives/hypnotics or mood stabilizers four weeks prior to the screening e) Complementary or alternative treatment used simultaneously to the study (e.g., acupuncture, phytotherapy, psychotherapy, etc.) f) Homeopathic treatment for any chronic diseases eight weeks prior to study entry g) Cases suffering from uncontrolled systemic illness or life-threatening infections h) Vulnerable population: unconscious, ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, mentally incompetent people. i) Self-reported immune-compromised state j) Pregnant and puerperal women, lactating mothers k) Patient under tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence l) Simultaneous participation in any other clinical trial
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| DASS-21 (Depression, Anxiety and Stress Scale 21)Timepoint: Baseline, after 3 months, and 6 months | — |
Secondary
| Measure | Time frame |
|---|---|
| PHQ-9 (Patient Health Questionnaire)Timepoint: Baseline, every month, up to 6 months | — |
Countries
India
Contacts
Public ContactSubhasish Ganguly
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed